XML 34 R15.htm IDEA: XBRL DOCUMENT
v3.8.0.1

STOCK COMPENSATION PLANS | 12 Months Ended
--- | ---
Dec. 31, 2017
STOCK COMPENSATION PLANS [Abstract] |
STOCK COMPENSATION PLANS | NOTE 8 STOCK COMPENSATION PLANS On December 9, 2015, the Company's stockholders approved the 2015 Equity Compensation Plan, or the 2015 Plan, that replaced the 2005 Equity Compensation Plan, or the 2005 Plan, which expired on May 24, 2015. The 2015 Plan provides that grants may be in any of the following forms: incentive stock options, nonqualified stock options, stock units, stock awards, dividend equivalents and other stock-based awards. The 2015 Plan is administered and interpreted by the Compensation Committee of the Board of Directors, or the Committee. The Committee has the authority to determine the individuals to whom grants will be made under the 2015 Plan, determine the type, size and terms of the grants, determine the time when grants will be made and the duration of any applicable exercise or restriction period (subject to the limitations of the 2015 Plan) and deal with any other matters arising under the 2015 Plan. The Committee presently consists of three directors, each of whom is a non-employee director of the Company. All of the employees of the Company and its subsidiaries are eligible for grants under the 2015 Plan. Non-employee directors of the Company are also eligible to receive grants under the 2015 Plan. The following summary reflects changes in the shares of Class A Stock under option:
|  | 2017 Shares |  |  | 2017 Weighted Average Exercise Price |  |  | 2016 Shares |  |  | 2016 Weighted Average Exercise Price |  |  | 2015 Shares |  |  | 2015 Weighted Average Exercise Price |
Plan options |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at beginning of year |  |  | 231,755 |  |  | $ | 19.32 |  |  |  | 270,000 |  |  | $ | 19.34 |  |  |  | 376,250 |  |  | $ | 19.52 |
Granted |  |  | — |  |  |  | — |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Exercised |  |  | (54,953 | ) |  |  | 17.42 |  |  |  | (38,245 | ) |  |  | 19.50 |  |  |  | (106,250 | ) |  |  | 19.97 |
Expired |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Outstanding at end of year |  |  | 176,802 |  |  | $ | 19.91 |  |  |  | 231,755 |  |  | $ | 19.32 |  |  |  | 270,000 |  |  | $ | 19.34 |
Options exercisable at year end |  |  | 176,802 |  |  | $ | 19.91 |  |  |  | 231,755 |  |  | $ | 19.32 |  |  |  | 270,000 |  |  | $ | 19.34 |
The total intrinsic value of options exercised during 2017, 2016 and 2015 were $1,198,000, $351,000 and $379,000, respectively. During 2017, we received $957,000 in cash from the exercise of options, with a $1,400,000 tax benefit realized for those options. The following tables summarize information about employee and director stock options outstanding at December 31, 2017:
Options Outstanding |  |  |  |  |  |
Range of Exercise Price |  |  | Shares Outstanding at December 31, 2017 |  | Weighted Average Remaining Life | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |
| $ | 15.26 - $18.61 |  |  |  | 41,802 |  | 1.99 Years |  | $ | 17.52 |  |  | $ | 879,409 |
| $ | 18.62 - $22.66 |  |  |  | 135,000 |  | 4.86 Years |  | $ | 20.64 |  |  | $ | 2,418,187 |
Options Exercisable |  |  |  |  |  |  |  |  |  |  |  |  |  |
Range of Exercise Price |  |  | Shares Exercisable at December 31, 2017 |  | Weighted Average Remaining Life | Weighted Average Exercise Price |  | Aggregate Intrinsic Value |
| $ | 15.26 - $18.61 |  |  |  | 41,802 |  | 1.99 Years |  | $ | 17.52 |  |  | $ | 879,409 |
| $ | 18.62 - $22.66 |  |  |  | 135,000 |  | 4.86 Years |  | $ | 20.64 |  |  | $ | 2,418,187 |
As of December 31, 2017, there was no unrecognized expense related to non-vested option shares granted under the Plan. The following summary reflects changes in the shares of Class A Stock Restricted Stock Awards (RSA):
|  | 2017 Shares |  |  | 2017 Weighted Average Grant Date Fair Value |  |  | 2016 Shares |  |  | 2016 Weighted Average Grant Date Fair Value |  |  | 2015 Shares |  |  | 2015 Weighted Average Exercise Price |
Plan RSA's |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding at beginning of year |  |  | 5,000 |  |  | $ | 27.70 |  |  |  | - |  |  | $ | - |  |  |  | - |  |  | $ | - |
Granted |  |  | 11,568 |  |  |  | 38.08 |  |  |  | 5,000 |  |  |  | 27.70 |  |  |  | 5,000 |  |  |  | 27.38 |
Vested/Released |  |  | (11,568 | ) |  |  | 33.58 |  |  |  | - |  |  |  | - |  |  |  | (5,000 | ) |  |  | 27.38 |
Cancelled |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Unvested Outstanding at end of year |  |  | 5,000 |  |  | $ | 38.10 |  |  |  | 5,000 |  |  | $ | 27.70 |  |  |  | - |  |  | $ | - |
On June 28, 2017, 6,568 shares of Class A common stock were issued as fully vested restricted stock awards. The fair market value per share was $38.06, the closing price of the Class A common stock as recorded on the Nasdaq Global Market on June 28, 2017. On May 3, 2017, 5,000 shares of Class A common stock, or Class A Stock, were granted as restricted stock awards. The fair value per share was $38.10, the closing price of the Class A Stock as recorded on the Nasdaq Global Market on May 3, 2017. The restricted shares are subject to a one year vesting period from the date of grant. Prior to their release date, these restricted stock awards may be subject to forfeiture in the event of the recipient's termination of service. On May 4, 2016, 5,000 shares of Class A common stock were granted as restricted stock awards. The fair market value per share was $27.70, the closing price of the Class A common stock as recorded on the Nasdaq Global Market on May 4, 2016. The restricted shares vest one year from the date of grant. On December 18, 2015, 5,000 shares of Class A common stock were issued as fully vested unrestricted stock awards. The fair market value per share was $27.38, the closing price of the Class A common stock as recorded on the Nasdaq Global Market on December 18, 2015. As of December 31, 2017, there was $63,700 total unrecognized expense related to non-vested awards of restricted shares awarded under the 2015 Plan. The cost will be recognized over 0.33 years, the remaining vesting period for the restricted stock awards. The total intrinsic value of awards released during 2017 was approximately $441,000.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration